Rhelixa
Tokyo
About Rhelixa
Rhelixa is a leader in epigenome analysis.We analyze genomes, epigenomes, and transcriptomes using our proprietary technologies to dramatically improve the efficiency and accuracy of R & D.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $1K – $10K
- Total funding: $5.6M
- Funding stage: Early Stage Venture
- Last round: Debt Financing (Aug 2024)
- Website: rhelixa.com
- Phone: +81 03-6240-9330
Industries & Categories
Analytics, Big Data, Biotechnology, Health Care
Social Profiles
Canonical: https://fsome.com/organization/rhelixa-6234 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.